Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Neurology
|
July 19, 2020
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
David Bäckström, Jan Linder, Susanna Jakobson Mo, et al.
Nuclear Medicine Communications
|
August 2, 2013
¹²³I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools
Susanna Jakobson Mo, Anne Larsson, Jan Linder, et al.
Journal of Neurology
|
June 2, 2009
Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort
Jan Linder, Richard Birgander, Ingegerd Olsson, et al.
Parkinson'S Disease
|
October 19, 2011
Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on diadochokinetic rate
Fredrik Karlsson, Elin Unger, Sofia Wahlgren, et al.
Journal of the Neurological Sciences
|
October 10, 2017
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study
David Bäckström, Magdalena Eriksson Domellöf, Gabriel Granåsen, et al.
Plos One
|
December 16, 2014
Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism
Sofie Degerman, Magdalena Domellöf, Mattias Landfors, et al.
Parkinson'S Disease
|
October 27, 2011
Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on voice intensity
Sofie Lundgren, Thomas Saeys, Fredrik Karlsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 20, 2018
Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand <sup>18</sup>F-FE-PE2I in Human Subjects
Helena Lizana, Lennart Johansson, Jan Axelsson, et al.
Neuroscience Letters
|
August 24, 2017
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Victoria Berge-Seidl, Lasse Pihlstrøm, Jodi Maple-Grødem, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 2, 2018
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation
Patric Blomstedt, Rasmus Stenmark Persson, Gun-Marie Hariz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Neurology
|
July 19, 2020
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
David Bäckström, Jan Linder, Susanna Jakobson Mo, et al.
Nuclear Medicine Communications
|
August 2, 2013
¹²³I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools
Susanna Jakobson Mo, Anne Larsson, Jan Linder, et al.
Journal of Neurology
|
June 2, 2009
Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort
Jan Linder, Richard Birgander, Ingegerd Olsson, et al.
Parkinson'S Disease
|
October 19, 2011
Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on diadochokinetic rate
Fredrik Karlsson, Elin Unger, Sofia Wahlgren, et al.
Journal of the Neurological Sciences
|
October 10, 2017
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study
David Bäckström, Magdalena Eriksson Domellöf, Gabriel Granåsen, et al.
Plos One
|
December 16, 2014
Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism
Sofie Degerman, Magdalena Domellöf, Mattias Landfors, et al.
Parkinson'S Disease
|
October 27, 2011
Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on voice intensity
Sofie Lundgren, Thomas Saeys, Fredrik Karlsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 20, 2018
Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand <sup>18</sup>F-FE-PE2I in Human Subjects
Helena Lizana, Lennart Johansson, Jan Axelsson, et al.
Neuroscience Letters
|
August 24, 2017
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Victoria Berge-Seidl, Lasse Pihlstrøm, Jodi Maple-Grødem, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 2, 2018
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation
Patric Blomstedt, Rasmus Stenmark Persson, Gun-Marie Hariz, et al.
Page
of 6